Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Condition: Medulloblastoma Interventions: Procedure: Surgical resection; Procedure: Ommaya/VPS; Drug: Methotrexate; Drug: Cisplatin; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Topotecan; Drug: Etoposide; Drug: Pegfilgrastim; Drug: Filgrastim; Radiation: Irradiation Sponsor: St. Jude Children's Research Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
Condition: Medulloblastoma, Childhood Intervention: Other: Prospective observational study, no intervention Sponsors: Beijing Tiantan Hospital; Beijing Neurosurgical Institute; Beijing Children's Hospital; Beijing Shijitan Hospital, Capital Medical University; Xuanwu Hospital, Beijing; Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2022 Category: Research Source Type: clinical trials
